Search Results - "Eloy Roman"

Intensity-Modulated Radiotherapy With Concurrent Chemotherapy for Previously Irradiated, Recurrent Head and Neck Cancer by Biagioli, Matthew C., M.D., M.S, Harvey, Mark, M.D, Roman, Eloy, M.D, Raez, Luis E., M.D, Wolfson, Aaron H., M.D, Mutyala, Subhakar, M.D, Han, Hyo S., M.D, Markoe, Arnold, M.D., Sc.D

“…Purpose Primary treatment fails in >70% of locally advanced head and neck cancer patients. Salvage therapy has a 30–40% response rate, but few long-term…”
Get full text

New targets for non-small-cell lung cancer therapy by Alvarez, Manrique, Roman, Eloy, Santos, Edgardo S, Raez, Luis E

“…Lung cancer remains the leading cause of malignancy-related deaths in the USA, regardless of advances in therapeutic agents. Non-small-cell lung cancer…”
Get full text

Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE) by Jilma, Bernd, Roman, Eloy, Ueda, Yasutaka, Mappa, Silvia, Szamosi, Johan, Savage, Jessica, Roeth, Alexander

Get full text

C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab by Castro, Carlos, Grossi, Federico, Weitz, Ilene Ceil, Maciejewski, Jaroslaw, Sharma, Vivek, Roman, Eloy, Brodsky, Robert A., Tan, Lisa, Di Casoli, Carl, El Mehdi, Delphine, Deschatelets, Pascal, Francois, Cedric

“…Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, life‐threatening hematologic disease characterized by chronic complement‐mediated hemolysis and…”
Get full text

A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia by Derman, Richard, Roman, Eloy, Modiano, Manuel R., Achebe, Maureen M., Thomsen, Lars L., Auerbach, Michael

“…Iron deficiency anemia (IDA) is common in many chronic diseases, and intravenous (IV) iron offers a rapid and efficient iron correction. This trial compared…”
Get full text

Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia by Roman, Eloy, Fattizzo, Bruno, Shum, Merrill Kingman, Hanna, Wahid T, Lentz, Steven R, Araujo, Sergio Schusterschitz S, Al-Adhami, Mohammed, Grossi, Federico V, Gertz, Morie A

“…Cold agglutinin disease (CAD) and warm antibody autoimmune hemolytic anemia (wAIHA) are rare autoimmune hemolytic anemias characterized by red blood cell…”
Get full text

Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria by Wong, Raymond S. M., Pullon, Humphrey W. H., Amine, Ismail, Bogdanovic, Andrija, Deschatelets, Pascal, Francois, Cedric G., Ignatova, Kalina, Issaragrisil, Surapol, Niparuck, Pimjai, Numbenjapon, Tontanai, Roman, Eloy, Sathar, Jameela, Xu, Raymond, Al-Adhami, Mohammed, Tan, Lisa, Tse, Eric, Grossi, Federico V.

“…Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematologic disorder characterized by complement-mediated hemolysis. C5 inhibitors…”
Get full text

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA) by Grossi, Federico, Shum, Merrill Kingman, Gertz, Morie A., Roman, Eloy, Deschatelets, Pascal, Hamdani, Mohamed, Stout, Frank, Francois, Cedric G

“…Background: Autoimmune hemolytic anemia (AIHA) is a rare autoimmune disease characterized by hemolysis mediated by autoantibodies directed against red blood…”
Get full text

C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials by Wong, Raymond S, Ignatova, Kalina, Pullon, Humphrey, Sathar, Jameela, Niparuck, Pimjai, Numbenjapon, Tontanai, Tse, Eric, Issaragrisil, Surapol, Roman, Eloy, Amine, Ismail, Tan, Lisa, Di Casoli, Carl, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Bogdanovic, Andrija

“…INTRODUCTION Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, clonal hematopoietic stem cell disorder characterized by chronic complement-mediated…”
Get full text

RX 3117: Activity of an oral antimetabolite nucleoside in subjects with pancreatic cancer–Preliminary results of stage II of the phase Ia/IIb study by Chung, Vincent M., Merchan, Jaime R., Ocean, Allyson J., Rasco, Drew W., Babiker, Hani M., Oliff, Ira, Paluri, Ravi Kumar, Roman, Eloy, Poore, Julie, Benaim, Ely

“…Abstract only 396 Background: RX-3117 is an oral small-molecule antimetabolite, cyclopentyl pyrimidyl nucleoside that is activated by uridine cytidine kinase…”
Get full text

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia by Derman, Richard, Roman, Eloy, Smith‐Nguyen, Gioi N., Achebe, Maureen M., Thomsen, Lars L., Auerbach, Michael

Get full text

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context by Prasanna Jagannathan, Kara W. Chew, Mark J. Giganti, Michael D. Hughes, Carlee Moser, Mark J. Main, Phillip D. Monk, Arzhang Cyrus Javan, Jonathan Z. Li, Courtney V. Fletcher, Caitlyn McCarthy, David A. Wohl, Eric S. Daar, Joseph J. Eron, Judith S. Currier, Upinder Singh, Davey M. Smith, William Fischer, Kara Chew, David (Davey) Smith, Eric Daar, David Wohl, Judith Currier, Joseph Eron, Arzhang Cyrus Javan, Michael Hughes, Carlee Moser, Mark Giganti, Justin Ritz, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott Sieg, Jonathan Li, Courtney Fletcher, William Fischer, Teresa Evering, Rachel Bender Ignacio, Sandra Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Alan Perelson, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Mark J. Main, Gerald Pierone, Juliana Elliott, Jeffrey Jacobson, Leila Hojat, Julie Pasternak, Jonathan Berardi, Celine Arar, Yevgeniy Bukhman, Manish Jain, Eugene Bukhman, Sadia Shaik, Timothy Hatlen, Kelly Dooley, Becky Becker, Adaliah Wilkins, Jose Pérez, Eloy Roman, Heriberto Fernández, Keila Hoover, James Renfroe, Mauney Weldon, Genei Bougher, Carlos Malvestutto, Heather Harber, Robyn Cicarella, Gene Neytman, Jack Herman, Craig Herman, Mariam Aziz, Joan Swiatek, Divya Pathak, Madhu Choudhary, Jennifer Sullivano, Olayemi Osiyemi, Myriam Izquierdo, Odelsey Torna, Aleen Khodabakhshian, Samantha Fortier, Constance Benson

“…Background: With the emergence of SARS-CoV-2 variants resistant to monoclonal antibody therapies and limited global access to therapeutics, the evaluation of…”
Get full text

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC) by Raez, Luis E., Santos, Edgardo S., Lopes, Gilberto, Rosado, Manuel F., Negret, Lawrence M., Rocha-Lima, Caio, Tolba, Kalhed, Farfan, Nancy, Hamilton-Nelson, Kara, Silva, Orlando, Roman, Eloy

“…Platinum-based doublets are recommended as treatment for advanced or metastatic non-small-cell lung cancer (NSCLC); however, chemotherapy must be tailored to…”
Get full text

Induction chemotherapy in the management of squamous cell carcinoma of the head and neck by Roman, Eloy, Raez, Luis E, Santos, Edgardo S

“…Platinum-based chemotherapy administered concurrently with radiation has been adopted as the standard treatment for locally advanced head and neck squamous…”
Get full text